“Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring”, Can Diabetes Endocrinol Today, vol. 4, no. 1, pp. 10–16, May 2026, doi: 10.58931/cdet.2026.4150.